FDA Adverse Event Injury Summary report: N

DESARA BLUE

MDR report key: 16486487 · Received March 6, 2023

Report

Report Number
3003990090-2023-01552
Event Type
Injury
Date Received
March 6, 2023
Date of Event
October 10, 2022
Report Date
March 3, 2023
Manufacturer
CALDERA MEDICAL
Product Code
OTN
UDI-DI
00890594000650
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IN, US
Reporter Occupation
OTHER

Narratives

Description of Event or Problem · 0

PER (B)(4) STUDY, IT WAS REPORTED; URINARY RETENTION REQUIRING CATHETERIZATION ON (B)(6) 2022. EVENT TREATED BY SUBJECT SELF-CATHETERIZING, AND PYRIDIUM AND BACTRIM. EVENT IS CONSIDERED RESOLVED. CEC ADJUDICATED EVENT POSSIBLY RELATED TO DEVICE/PRODUCT AND/OR PROCEDURE. URINARY TRACT INFECTION (B)(6) 2022, EVENT TREATED WITH CIPRO AND IS CONSIDERED RESOLVED. CEC ADJUDICATED NOT RELATED TO DEVICE/PRODUCT. WORSENING URGENCY ON (B)(6) 2022. EVENT HAS BEEN TREATED WITH OXYBUTYNIN CR AND MYRBETRIQ. CEC ADJUDICATED EVENT IS POSSIBLY RELATED TO DEVICE/PRODUCT. DYSURIA ON (B)(6) 2022, REQUIRED MEDICAL INTERVENTION AND IS RESOLVING. CEC ADJUDICATED EVENT IS POSSIBLY RELATED TO DEVICE/PRODUCT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
863849 DESARA BLUE DESARA BLUE OTN CALDERA MEDICAL N04041 00890594000650

Patients

Seq Age Sex Outcome Treatment
1 45 YR Female Other| H